# A Health Economic Evaluation of Using N-Terminal Pro Brain Natriuretic Peptide (NT-Pro BNP) in Acute Heart Failure

> **NCT03669198** · NA · COMPLETED · sponsor: **Heart Failure Biomarker Group** · enrollment: 56 (actual)

## Conditions studied

- Heart Failure

## Interventions

- **DIAGNOSTIC_TEST:** NT-Pro BNP

## Key facts

- **NCT ID:** NCT03669198
- **Lead sponsor:** Heart Failure Biomarker Group
- **Sponsor class:** INDIV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-01
- **Primary completion:** 2018-02-15
- **Final completion:** 2018-05-31
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2018-09-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03669198

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03669198, "A Health Economic Evaluation of Using N-Terminal Pro Brain Natriuretic Peptide (NT-Pro BNP) in Acute Heart Failure". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT03669198. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*